oral glutathione and diabetes Oxidative Stress, Insufficiency, Inflammatory Pathways in Type 2 Mellitus: Implications for Therapeutic Interventions Diabetes Type 1 Type 2:
Description
The standard subcutaneous injection dose is 0.51.0mL weekly, administered into the fatty tissue of the abdomen or lateral thigh

Evidence of benefit in humans does not exist

doi: 10.3389/fnins.2014.00380

Two hundred and fifty L of sample plasma was spiked with 10 L of IS and then deproteinated by mixing the plasma sample with 380 L of acetonitrile and kept at room temperature for 20 min